Who owns MRKWhat MRK owns
What Merck & Co., Inc. owns
The company's own 13F portfolio · as of 2026-09-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$820.3M
disclosed stock portfolio
13
positions
54.2%
in MRNA
Positions, as of 2026-09-30
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | MRNAMODERNA INC | 2.3M | $444.5M | 54.2% |
| 2 | PSNLPERSONALIS INC | 14.0M | $228.7M | 27.9% |
| 3 | KYMRKYMERA THERAPEUTICS INC | 772,165 | $86.3M | 10.5% |
| 4 | AKTSAKTIS ONCOLOGY INC | 952,844 | $18.6M | 2.3% |
| 5 | EIKNEIKON THERAPEUTICS INC | 1.7M | $13.4M | 1.6% |
| 6 | TRDAENTRADA THERAPEUTICS INC | 1.7M | $11.0M | 1.3% |
| 7 | ALECALECTOR INC | 3.5M | $6.6M | 0.8% |
| 8 | STROSUTRO BIOPHARMA INC | 272,351 | $4.4M | 0.5% |
| 9 | EVAXEVAXION AS | 1.2M | $4.0M | 0.5% |
| 10 | VRDNVIRIDIAN THERAPEUTICS INC | 93,414 | $1.9M | 0.2% |
| 11 | XLOXILIO THERAPEUTICS INC | 105,982 | $959,137 | 0.1% |
| 12 | HURATUHURA BIOSCIENCES INC | 19,445 | $40,834 | 0% |
| 13 | NEUPNEUPHORIA THERAPEUTICS INC | 10,027 | $35,696 | 0% |
Source: SEC Form 13F-HR filed by Merck & Co., Inc. (CIK 310158), reporting period 2026-09-30. Values are quarter-end filed marks. Research, not investment advice.